芎芍胶囊治疗冠心病心绞痛心血瘀阻证的临床分析

Clinical Analysis of Xiongshao Capsule on Angina Pectoris of Coronary Heart Disease with Blood Stasis Syndrome

目的:对芎芍胶囊在冠心病心绞痛心血瘀阻证治疗中的临床应用效果进行探讨。方法:选取2014年3月—2015年3月我院所接收的72例冠心病心绞痛心血瘀阻证患者作为观察对象,按就诊前后顺序分成对照组与实验组,分别予以血府逐瘀胶囊与芎芍胶囊加以治疗,且对比两组患者的治疗效果。结果:实验组患者的有效率(94.4%)显著高于对照组患者(80.6%),存在显著性差异,有统计学意义(P<0.05)。结论:对冠心病心绞痛心血瘀阻证患者予以芎芍胶囊进行治疗,效果确切,值得大力推广与运用。

Objective：To explore the clinical effect of Xiongshao Capsule on angina pectoris of coronary heart disease in the treatment of blood stasis syndrome.Methods：Selected 2014 March to 2015 march in our hospital received 72 cases of angina pectoris of coronary heart disease with blood stasis syndrome patients as the observation object, according to order before and after the treatment were divided into two groups,control group and experimental group, respectively, to be Xuefu by stasis capsule and xiongshao capsule treatment, and were compared between the 2 groups of treatment effect. Results：Efficiency （94.4%） patients in the experimental group was significantly higher than that of the control group patients （80.6%）, there are significant differences have statistical significance （P〈0.05）.Conclusion：In patients with angina pectoris of coronary heart disease with blood stasis syndrome be xiongshao capsule treatment, the exact effect, it is worth popularizing and applying.